CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9934-9946

  Zhen, Anjie ^a   Krutzik, Stephan R ^a   Levin, Bernard R ^a   Kasparian, Saro ^a   Zack, Jerome A ^a   Kitchen, Scott G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; HLA ANTIGEN CLASS 2; PROTEIN BINDING;

ADULT; CELL DIFFERENTIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MACROPHAGE; METABOLISM; MONOCYTE; PHYSIOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD4; CELL DIFFERENTIATION; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV INFECTIONS; HUMANS; MACROPHAGES; MONOCYTES; PROTEIN BINDING; SIGNAL TRANSDUCTION;

EID: 84921951345     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00616-14     Document Type: Article

References (76)

1. Auffray C, Sieweke MH, Geissmann F. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27:669-692. 10.1146/annurev.immunol.021908.132557.
2. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, Kayal S, Sarnacki S, Cumano A, Lauvau G, Geissmann F. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317:666-670. 10.1126/science.1142883.
3. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327:656-661. 10.1126/science.1178331.
4. Martinez FO, Helming L, Gordon S. 2009. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 27:451-483. 10.1146/annurev.immunol.021908.132532.
5. Montoya D, Cruz D, Teles RM, Lee DJ, Ochoa MT, Krutzik SR, Chun R, Schenk M, Zhang X, Ferguson BG, Burdick AE, Sarno EN, Rea TH, Hewison M, Adams JS, Cheng G, Modlin RL. 2009. Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe 6:343-353. 10.1016/j.chom.2009.09.002.
6. Krutzik SR, Tan B, Li H, Ochoa MT, Liu PT, Sharfstein SE, Graeber TG, Sieling PA, Liu YJ, Rea TH, Bloom BR, Modlin RL. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11:653-660. 10.1038/nm1246.
7. Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, Modlin RL. 2008. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol. 181:7115-7120. 10.4049/jimmunol.181.10.7115.
8. Crocker PR, Jefferies WA, Clark SJ, Chung LP, Gordon S. 1987. Species heterogeneity in macrophage expression of the CD4 antigen. J. Exp. Med. 166:613-618. 10.1084/jem.166.2.613.
9. Lynch GW, Turville S, Carter B, Sloane AJ, Chan A, Muljadi N, Li S, Low L, Armati P, Raison R, Zoellner H, Williamson P, Cunningham A, Church WB. 2006. Marked differences in the structures and protein associations of lymphocyte and monocyte CD4: resolution of a novel CD4 isoform. Immunol. Cell Biol. 84:154-165. 10.1111/j.1440-1711.2005.01403.x.
10. Maddon PJ, Littman DR, Godfrey M, Maddon DE, Chess L, Axel R. 1985. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family. Cell 42:93-104. 10.1016/S0092-8674(85)80105-7.
11. Ravichandran KS, Collins TL, Burakoff SJ. 1996. CD4 and signal transduction. Curr. Top. Microbiol. Immunol. 205:47-62.
12. Pelchen-Matthews A, da Silva RP, Bijlmakers MJ, Signoret N, Gordon S, Marsh M. 1998. Lack of p56lck expression correlates with CD4 endocytosis in primary lymphoid and myeloid cells. Eur. J. Immunol. 28:3639-3647. 10.1002/(SICI)1521-4141(199811)28:11<3639::AID-IMMU3639>3.0.CO;2-Q.
13. Stevenson M. 2003. HIV-1 pathogenesis. Nat. Med. 9:853-860. 10.1038/nm0703-853.
14. Perno CF, Svicher V, Schols D, Pollicita M, Balzarini J, Aquaro S. 2006. Therapeutic strategies towards HIV-1 infection in macrophages. Antiviral Res. 71:293-300. 10.1016/j.antiviral.2006.05.015.
15. Ancuta P, Kunstman KJ, Autissier P, Zaman T, Stone D, Wolinsky SM, Gabuzda D. 2006. CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344:267-276. 10.1016/j.virol.2005.10.027.
16. Crowe SM, Westhorpe CLV, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. 2010. The macrophage: the intersection between HIV infection and atherosclerosis. J. Leukoc. Biol. 87:589-598. 10.1189/jlb.0809580.
17. Ellery P, Tippett E, Chiu Y, Paukovics G, Cameron P, Solomon A, Lewin S, Gorry P, Jaworowski A, Greene W. 2007. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J. Immunol. 178:6581-6589. 10.4049/jimmunol.178.10.6581.
18. Jaworowski A, Kamwendo D, Ellery P, Sonza S, Mwapasa V, Tadesse E, Molyneux M, Rogerson S, Meshnick S, Crowe S. 2007. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J. Infect. Dis. 196:38-42. 10.1086/518443.
19. Ziegler-Heitbrock L. 2007. The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81:584-592. 10.1189/jlb.0806510.
20. Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L. 2002. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76:707-716. 10.1128/JVI.76.2.707-716.2002.
21. McElrath MJ, Pruett JE, Cohn ZA. 1989. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. U. S. A. 86:675-679. 10.1073/pnas.86.2.675.
22. Llewellyn N, Zioni R, Zhu H, Andrus T, Xu Y, Corey L, Zhu T. 2006. Continued evolution of HIV-1 circulating in blood monocytes with antiretroviral therapy: genetic analysis of HIV-1 in monocytes and CD4+ T cells of patients with discontinued therapy. J. Leukoc. Biol. 80:1118-1126. 10.1189/jlb.0306144.
23. Lewin SR, Kirihara J, Sonza S, Irving L, Mills J, Crowe SM. 1998. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 12:719-727. 10.1097/00002030-199807000-00008.
24. Lambotte O, Taoufik Y, de Goer MG, Wallon C, Goujard C, Delfraissy JF. 2000. Detection of infectious HIV in circulating monocytes from patients on prolonged highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 23:114-119. 10.1097/00126334-200002010-00002.
25. Fulcher JA, Hwangbo Y, Zioni R, Nickle D, Lin X, Heath L, Mullins JI, Corey L, Zhu T. 2004. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection. J. Virol. 78:7883-7893. 10.1128/JVI.78.15.7883-7893.2004.
26. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, Skillman D, Meltzer MS. 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J. Exp. Med. 167:1428-1441. 10.1084/jem.167.4.1428.
27. Orenstein JM, Meltzer MS, Phipps T, Gendelman HE. 1988. Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J. Virol. 62:2578-2586.
28. Garaci E, Aquaro S, Lapenta C, Amendola A, Spada M, Covaceuszach S, Perno CF, Belardelli F. 2003. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice. Proc. Natl. Acad. Sci. U. S. A. 100:8927-8932. 10.1073/pnas.1332627100.
29. Handunnetthi L, Ramagopalan SV, Ebers GC, Knight JC. 2010. Regulation of major histocompatibility complex class II gene expression, genetic variation and disease. Genes Immun. 11:99-112. 10.1038/gene.2009.83.
30. Thedrez A, de Lalla C, Allain S, Zaccagnino L, Sidobre S, Garavaglia C, Borsellino G, Dellabona P, Bonneville M, Scotet E, Casorati G. 2007. CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells. Blood 110:251-258. 10.1182/blood-2007-01-066217.
31. Milia E, Di Somma MM, Majolini MB, Ulivieri C, Somma F, Piccolella E, Telford JL, Baldari CT. 1997. Gene activating and proapoptotic potential are independent properties of different CD4 epitopes. Mol. Immunol. 34:287-296. 10.1016/S0161-5890(97)00050-3.
32. Kitchen SG, Jones NR, LaForge S, Whitmire JK, Vu BA, Galic Z, Brooks DG, Brown SJ, Kitchen CM, Zack JA. 2004. CD4 on CD8+ T cells directly enhances effector function and is a target for HIV infection. Proc. Natl. Acad. Sci. U. S. A. 101:8727-8732. 10.1073/pnas.0401500101.
33. Kitchen SG, LaForge S, Patel VP, Kitchen CM, Miceli MC, Zack JA. 2002. Activation of CD8 T cells induces expression of CD4, which functions as a chemotactic receptor. Blood 99:207-212. 10.1182/blood.V99.1.207.
34. Brooks DG, Arlen PA, Gao L, Kitchen CM, Zack JA. 2003. Identification of T cell-signaling pathways that stimulate latent HIV in primary cells. Proc. Natl. Acad. Sci. U. S. A. 100:12955-12960. 10.1073/pnas.2233345100.
35. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA. 2005. Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21:803-810. 10.1093/bioinformatics/bti038.
36. Kreutz M, Hennemann B, Ackermann U, Grage-Griebenow E, Krause SW, Andreesen R. 1999. Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-a and interleukin-10. Immunology 98:491-496. 10.1046/j.1365-2567.1999.00904.x.
37. Sallusto F, Lanzavecchia A. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J. Exp. Med. 179:1109-1118. 10.1084/jem.179.4.1109.
38. Clayton LK, Sieh M, Pious DA, Reinherz EL. 1989. Identification of human CD4 residues affecting class II MHC-versus HIV-1 gp120 binding. Nature 339:548-551. 10.1038/339548a0.
39. Kato M, Neil TK, Fearnley DB, McLellan AD, Vuckovic S, Hart DN. 2000. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol. 12:1511-1519. 10.1093/intimm/12.11.1511.
40. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
41. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:1526-1529. 10.1126/science.1093620.
42. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5:987-995. 10.1038/ni1112.
43. Baker RG, Hayden MS, Ghosh S. 2011. NF-[kappa]B, inflammation, and metabolic disease. Cell Metab. 13:11-22. 10.1016/j.cmet.2010.12.008.
44. Rosa A, Ballarino M, Sorrentino A, Sthandier O, De Angelis FG, Marchioni M, Masella B, Guarini A, Fatica A, Peschle C, Bozzoni I. 2007. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. U. S. A. 104:19849-19854. 10.1073/pnas.0706963104.
45. Nakayama H, Ishimaru F, Katayama Y, Nakase K, Sezaki N, Takenaka K, Shinagawa K, Ikeda K, Niiya K, Harada M. 2000. Ikaros expression in human hematopoietic lineages. Exp. Hematol. 28:1232-1238. 10.1016/S0301-472X(00)00530-0.
46. Cruikshank WW, Greenstein JL, Theodore AC, Center DM. 1991. Lymphocyte chemoattractant factor induces CD4-dependent intracytoplasmic signaling in lymphocytes. J. Immunol. 146:2928-2934.
47. Cruikshank WW, Berman JS, Theodore AC, Bernardo J, Center DM. 1987. Lymphokine activation of T4+ T lymphocytes and monocytes. J. Immunol. 138:3817-3823.
48. Graziani-Bowering G, Filion LG, Thibault P, Kozlowski M. 2002. CD4 is active as a signaling molecule on the human monocytic cell line Thp-1. Exp. Cell Res. 279:141-152. 10.1006/excr.2002.5581.
49. Rao KM. 2001. MAP kinase activation in macrophages. J. Leukoc. Biol. 69:3-10.
50. Tiwari RL, Singh V, Barthwal MK. 2008. Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med. Res. Rev. 28:483-544. 10.1002/med.20118.
51. Grivennikov SI, Karin M. 2010. Dangerous liaisons: STAT3 and NF-[kappa]B collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 21:11-19. 10.1016/j.cytogfr.2009.11.005.
52. Yu H, Pardoll D, Jove R. 2009. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9:798-809. 10.1038/nrc2734.
53. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. U. S. A. 92:7686-7689. 10.1073/pnas.92.17.7686.
54. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623-18632. 10.1074/jbc.273.29.18623.
55. Hers I, Tavare JM, Denton RM. 1999. The protein kinase C inhibitors bisindolylmaleimide I (GF 109203x) and IX (Ro 31-8220) are potent inhibitors of glycogen synthase kinase-3 activity. FEBS Lett. 460:433-436. 10.1016/S0014-5793(99)01389-7.
56. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi K, Inoue T, Naito K, Toshioka T, Hidaka H. 1990. Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265:5267-5272.
57. English JM, Cobb MH. 2002. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23:40-45. 10.1016/S0165-6147(00)01865-4.
58. Alexander I, Edelman ER, Methe H. 2009. Function and mode of regulation of endothelial major histocompatibility complex class II. Cell Transplant. 18:255-259. 10.3727/096368909788534997.
59. McDouall RM, Batten P, McCormack A, Yacoub MH, Rose ML. 1997. MHC-class II expression on human heart microvascular endothelial cells: exquisite sensitivity to interferon-gamma and natural killer cells. Transplantation 64:1175-1180. 10.1097/00007890-199710270-00016.
60. Pober JS, Collins T, Gimbrone MA Jr, Cotran RS, Gitlin JD, Fiers W, Clayberger C, Krensky AM, Burakoff SJ, Reiss CS. 1983. Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 305:726-729. 10.1038/305726a0.
61. Wedgwood JF, Hatam L, Bonagura VR. 1988. Effect of interferon-[gamma] and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Cell. Immunol. 111:1-9. 10.1016/0008-8749(88)90046-9.
62. Crowe SM, Sonza S. 2000. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J. Leukoc. Biol. 68:345-350.
63. Coleman C, Wu L. 2009. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6:51. 10.1186/1742-4690-6-51.
64. Collman R, Hassan N, Walker R, Godfrey B, Cutilli J, Hastings J, Friedman H, Douglas S, Nathanson N. 1989. Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). Monocyte-tropic and lymphocyte-tropic strains of HIV-1 show distinctive patterns of replication in a panel of cell types. J. Exp. Med. 170:1149-1163.
65. Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins J, Corey L. 2002. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J. Virol. 76:707-716. 10.1128/JVI.76.2.707-716.2002.
66. Conti L, Cardone M, Varano B, Puddu P, Belardelli F, Gessani S. 2008. Role of the cytokine environment and cytokine receptor expression on the generation of functionally distinct dendritic cells from human monocytes. Eur. J. Immunol. 38:750-762. 10.1002/eji.200737395.
67. Mach B, Steimle V, Martinez-Soria E, Reith W. 1996. Regulation of MHC-class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331. 10.1146/annurev.immunol.14.1.301.
68. Galkina E, Ley K. 2009. Immune and inflammatory mechanisms of atherosclerosis (*). Annu. Rev. Immunol. 27:165-197. 10.1146/annurev.immunol.021908.132620.
69. Woollard KJ, Geissmann F. 2010. Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7:77-86. 10.1038/nrcardio.2009.228.
70. Palacios EH, Weiss A. 2004. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23:7990-8000. 10.1038/sj.onc.1208074.
71. Krautwald S. 1998. IL-16 activates the SAPK signaling pathway in CD4+ macrophages. J. Immunol. 160:5874-5879.
72. Qi JC, Wang J, Mandadi S, Tanaka K, Roufogalis BD, Madigan MC, Lai K, Yan F, Chong BH, Stevens RL, Krilis SA. 2006. Human and mouse mast cells use the tetraspanin CD9 as an alternate interleukin-16 receptor. Blood 107:135-142. 10.1182/blood-2005-03-1312.
73. Hsue PY, Deeks SG, Hunt PW. 2012. Immunologic basis of cardiovascular disease in HIV-infected adults. J. Infect. Dis. 205(Suppl. 3):S375-S382. 10.1093/infdis/jis200.
74. Hunt PW. 2012. HIV and inflammation: mechanisms and consequences. Curr. HIV/AIDS Rep. 9:139-147. 10.1007/s11904-012-0118-8.
75. Li QJ, Dinner AR, Qi S, Irvine DJ, Huppa JB, Davis MM, Chakraborty AK. 2004. CD4 enhances T cell sensitivity to antigen by coordinating Lck accumulation at the immunological synapse. Nat. Immunol. 5:791-799. 10.1038/ni1095.
76. Parham P. 2009. The immune system, 3rd ed. Garland Science, New York, NY.